Analyzing Pgc1α, we found higher expression in pancreatic cancer patients (median 2.08 IQR 1.43; 3.47) vs. controls (median 1.17 IQR 0.68; 1.42) (p = 0.004) and vs. colorectal cancer patients (median 0.73 IQR 0.49; 1.47) (p = 0.008), and we found a similar trend, although not significant, vs. gastric patients (p = 0.159) (Figure 3A). This evidence concerns the gene PPARGC1A and familial pancreatic carcinoma.